BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 7212550)

  • 21. [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].
    Colin J; Harie JC
    J Fr Ophtalmol; 1989; 12(3):161-5. PubMed ID: 2695556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital toxoplasmosis with unusual retinal findings.
    Brady-McCreery KM; Hussein MA; Paysse EA
    Arch Ophthalmol; 2003 Aug; 121(8):1200-1. PubMed ID: 12912703
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides].
    Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
    Arch Fr Pediatr; 1991; 48(6):397-403. PubMed ID: 1929726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recommendations for the treatment of prenatal toxoplasma infection in the child. German Society of Pediatric Infectiology e.V. (DGPI), "Parasitology" Study Group].
    Döhring-Schwerdtfeger E; Leichsenring M; Liefke U; Padelt H; Sitzmann FC; Stehr K; Zimmermann PH
    Klin Padiatr; 1995; 207(1):38-41. PubMed ID: 7885018
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of ocular toxoplasmosis. Part 1: Basic principles and diagnosis].
    Mittelviefhaus H
    Kinderarztl Prax; 1993 May; 61(3):90-6. PubMed ID: 8326704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
    Phan L; Kasza K; Jalbrzikowski J; Noble AG; Latkany P; Kuo A; Mieler W; Meyers S; Rabiah P; Boyer K; Swisher C; Mets M; Roizen N; Cezar S; Remington J; Meier P; McLeod R;
    Ophthalmology; 2008 Mar; 115(3):553-559.e8. PubMed ID: 17825418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of subclinical congenital toxoplasmosis by sulfadiazine and pyrimethamine continuously during 1 year: apropos of 46 cases].
    Kieffer F; Thulliez P; Brézin A; Nobre R; Romand S; Yi-Gallimard E; Voyer M; Magny JF
    Arch Pediatr; 2002 Jan; 9(1):7-13. PubMed ID: 11865553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis].
    Psilas K; Petroutsos G; Aspiotis M
    J Fr Ophtalmol; 1990; 13(11-12):551-3. PubMed ID: 2081846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Toxoplasmosis-chorioretinitis: clinical course and treatment of seven patients].
    Lebech AM; Lebech M; Børme KK; Mathiesen LR
    Ugeskr Laeger; 1996 Jul; 158(27):3935-9. PubMed ID: 8701510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ocular toxoplasmosis. Apropos of 29 cases illustrating the various clinical and serological forms].
    Fontaine M; Desmonts G; Rousselie F
    Arch Ophtalmol Rev Gen Ophtalmol; 1965; 25(7):585-619. PubMed ID: 4221531
    [No Abstract]   [Full Text] [Related]  

  • 31. [Congenital ocular toxoplasmosis and late recurrences (author's transl)].
    François J
    J Fr Ophtalmol; 1981; 4(2):157-65. PubMed ID: 7240657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Strategies for the diagnosis and treatment of prenatal toxoplasmosis - a survey].
    Christoph J; Kattner E; Seitz HM; Reiter-Owona I
    Z Geburtshilfe Neonatol; 2004 Feb; 208(1):10-6. PubMed ID: 15039886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiology, clinical aspects and therapy of toxoplasmosis].
    Alexander M
    Med Klin; 1970 Feb; 65(7):283-8. PubMed ID: 5534813
    [No Abstract]   [Full Text] [Related]  

  • 34. [Congenital toxoplasmosis in the Alpes-Maritimes region. Apropos of 26 cases observed between 1984 and 1990].
    Ferret N; Marty P; Tordjman C; Deville A; Tommasi C; Velin P; Mariani R; Le Fichoux Y
    Pediatrie; 1992; 47(6):467-71. PubMed ID: 1331966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of toxoplasmosis].
    van der Veen J
    Ned Tijdschr Geneeskd; 1979 Apr; 123(14):564-6. PubMed ID: 431741
    [No Abstract]   [Full Text] [Related]  

  • 36. [Postnatal therapy for congenital toxoplasmosis: a comparison of 2 different treatment approaches].
    Pohl-Schickinger A; Feiterna-Sperling C; Weizsäcker K; Bührer C
    Z Geburtshilfe Neonatol; 2012 Apr; 216(2):73-6. PubMed ID: 22517047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of congenital toxoplasmosis.
    Wilson CB
    Pediatr Infect Dis J; 1990 Sep; 9(9):682-3. PubMed ID: 2235199
    [No Abstract]   [Full Text] [Related]  

  • 38. Unresolved questions about the most successful known parasite.
    Ajzenberg D
    Expert Rev Anti Infect Ther; 2011 Feb; 9(2):169-71. PubMed ID: 21342063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologic rebounds after one-year-long treatment for congenital toxoplasmosis.
    Djurkovic-Djakovic O; Romand S; Nobrè R; Couvreur J; Thulliez P
    Pediatr Infect Dis J; 2000 Jan; 19(1):81-3. PubMed ID: 10643858
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ocular toxoplasmosis in 1989].
    Bloch-Michel E
    Bull Soc Belge Ophtalmol; 1989; 230():53-8. PubMed ID: 2488435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.